Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized anti-CD3 variable regions

Optimized anti-CD3 variable regions

US Patent 10968276 · Granted Apr 6, 2021

Estimated economic value: $26,457,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Anti-human C5 antibodies2025
CTLA4-Ig immunoadhesins2025
Heterodimeric human IgG1 polypeptides with isoelectric point modifications2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025